GSTM1 and neoplasm: The Cur + TQ + DIM, Cur + DIM, Cur + TQ, and TQ + DIM treated implants exhibited more significant reductions in tumor weights and Hb concentrations of A549 and HepG2 cells’ implants compared with single drugs, Cur, TQ, and DIM.